AVECOR STOCK GAINS 21.5% IN AUGUST AS INVESTORS SHOW AFFINITY FOR ISSUE FOLLOWING BLOOD PUMP CLEARANCE; O-T-C INDEX ADVANCES 1.8% FOR THE MONTH
This article was originally published in The Gray Sheet
Executive Summary
Avecor Cardiovascular's U.S. launch of the Affinity blood pump in August helped attract investors to the company, boosting the issue 21.5% for the month. Avecor closed August at 12 -- up 2-1/8 points.